ATS Breathe Easy

Drs. Meghan Cirulis and Khushboo Goel discuss chronic thromboembolic pulmonary hypertension (CTEPH) with international expert, Dr. Kim Kerr. 

A practical case-based approach to the management of atrial fibrillation in the ICU.

Social media is taking on an ever increasing presence in medicine and academics. While it presents opportunities for outreach and networking, it also comes with many inherent challenges. In this podcast, we speak with seasoned ATS members who have successfully navigated social media in their professional spheres. Come join us for this low-key and fun discussion as they share their experiences and their perspectives on how early career professionals can leverage social media to advance their careers.

In this podcast, Astrid Blondeel and Mark Orme discuss the technical aspects of Physical Activity measurement in Pulmonary Rehabilitation. This includes defining physical activity, why measuring this is important and the merits/ pitfalls of subjective and objective measures.

Please join Dr. Ninotchka Sigua, as she chats with the ATS SRN Programming Chair, Dr. Andrey Zinchuk, about the exciting lineup of sleep-related programs at ATS 2023. This podcast will provide an excellent overview of the sleep content and program.   Details of the program is available on the Advance Program Catalog available on the conference website.

In this podcast, we explore the groundbreaking world of tele-rehabilitation and how it is transforming the healthcare industry. Tele-rehabilitation is the practice of providing rehabilitation services to patients in remote locations through the use of technology. We discuss the benefits of tele-rehabilitation, including increased accessibility, convenience, and cost-effectiveness for patients. Our experts delve into the various applications of tele-rehabilitation, including its use in pulmonary rehabilitation, neurological conditions, and eduation. 

In this podcast episode, Dr Ashesha Mechineni interviews Dr Bharati Prasad, Associate Professor of Medicine and Medical Director of UIC Sleep Science Center and Program Director of Sleep fellowship at University of Illinois at Chicago. This is the conclusion of our core discussion on Health Disparities in Obstructive Sleep Apnea. Dr Prasad explains how Positive airway pressure treatment variables vary across various treatment groups and how real life factors play a role in overall long term clinical outcomes. She explores variations in research results among COVID 19 pandemic patients with obstructive sleep apnea as she draws to a close. 

This podcast is a discussion with Dr Susan Redline, Professor of Sleep Medicine at Brigham and Women's Hospital about the current burden of health disparities among Obstructive sleep apnea patients. Spotlight placed on etiological ,pathophysiological and clinical differences among various racial, gender groups along with their clinical implications. Dr Redline's perspective on long term outlook regarding diagnostic modalities used routinely in Sleep practices and future direction of sleep research are discussed. 

A discussion of vaccine information, hesitancy and uptake among multiple populations and how we can improve uptake in our daily practices Show ReferencesMcElfish PA, Willis DE, Shah SK, Bryant-Moore K, Rojo MO, Selig JP. Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy. J Prim Care Community Health. Jan-Dec 2021;12:21501327211040746. doi:10.1177/21501327211040746 MacDonald NE, Hesitancy SWGoV. Vaccine hesitancy: Definition, scope and determinants. Vaccine. Aug 14 2015;33(34):4161-4. doi:10.1016/j.vaccine.2015.04.036 Nguyen LH, Joshi AD, Drew DA, et al. Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake. medRxiv. Feb 28 2021;doi:10.1101/2021.02.25.21252402 Wong LP, Alias H, Danaee M, et al. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries. Infect Dis Poverty. Oct 7 2021;10(1):122. doi:10.1186/s40249-021-00900-w Jacobson RM, St Sauver JL, Finney Rutten LJ. Vaccine Hesitancy. Mayo Clin Proc. Nov 2015;90(11):1562-8. doi:10.1016/j.mayocp.2015.09.006 S. B. Omer, D. A. Salmon, W. A. Orenstein, M. P. deHart and N. Halsey. Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases. NEJM 2009 Vol. 360 Issue 19 Pages 1981-1988 Lila J. Finney Rutten, Xuan Zhu, Aaron L. Leppin, Jennifer L. Ridgeway, Melanie D. Swift, Joan M. Griffin, Jennifer L. St Sauver, Abinash Virk, Robert M. Jacobson. Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy. Mayo Clinic Proceedings. Volume 96, Issue 3. 2021. Pages 699-707. Raymond John D Vergara, Philip Joseph D Sarmiento, James Darwin N Lagman, Building public trust: a response to COVID-19 vaccine hesitancy predicament, Journal of Public Health, Volume 43, Issue 2, June 2021, Pages e291–e292, https://doi.org/10.1093/pubmed/fdaa282 Corbie-Smith G. Vaccine Hesitancy Is a Scapegoat for Structural Racism. JAMA Health Forum. 2021;2(3):e210434. doi:10.1001/jamahealthforum.2021.0434The 'successful failures' of Apollo 13 and Covid-19 vaccination - STAT (statnews.com)

Tidal Volume is a podcast from ATS Peds focusing on core concepts of pediatric pulmonology. The goal is to bring in depth focus on these core concepts for residents, fellows, early career pulmonologists or even senior faculty looking for a refresher.In episode 7, Ryan Thomas MD from Michigan State University discusses tracheobronchitis in children with tracheostomy tubes with Dan Craven MD and Moshe Prero MD from Case Western Reserve University/Rainbow Babies and Children’s Hospital and Alexander Gipsman MD from Children’s Hospital  of Philadelphia. We discuss their review article Tracheobronchitis in children with tracheostomy tubes: Overview of a challenging problem and why they decided to write on this topic.  We also discuss the importance of tracheobronchitis in this patient population, the risk factors for infection, the microbiology of the airway,  and the diagnosis and treatment of tracheobronchitis in children with tracheostomy tubes.  Guests:  Daniel Craven, MD, Case Western Reserve UniversityMoshe Prero, MD, Case Western Reserve UniversityAlexander Gipsman, MD, Children's Hospital of Philadelphia Host:  Ryan Thomas, MD,  Michigan State University ReviewersChristina Barreda, MD, University of Wisconsin Elizabeth Fiorino, MD, Hofstra University Production/EditingRyan Thomas, MD,  Michigan State University Contact Information:TidalVolumeATSPeds@gmail.com Twitter Accounts:Ryan Thomas, MD@MSUPedsPulm@ATSPeds References Gipsman A, Prero M, Toltzis P, Craven D. Tracheobronchitis in children with tracheostomy tubes: Overview of a challenging problem. Pediatr Pulmonol. 2022 Apr;57(4):814-821.Akangire G, Manimtim W, Nyp M, et al. Factors leading to rehospitalization for tracheostomized and ventilator-dependent infants through 2 years of age. J Perinatol. 2017;37(7):857-863.Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-332. Griese M, Felber J, Reiter K, et al. Airway inflammation in children with tracheostomy. Pediatr Pulmonol. 2004;37(4):356-361. Willson DF, Conaway M, Kelly R, Hendley JO. The lack of specificity of tracheal aspirates in the diagnosis of pulmonary infection in intubated children. Pediatr Crit Care Med. 2014;15(4):299-305. Cline JM, Woods CR, Ervin SE, Rubin BK, Kirse DJ. Surveillance tracheal aspirate cultures do not reliably predict bacteria cultured at the time of an acute respiratory infection in children with tracheostomy tubes. Chest. 2012;141(3):625-631. Rusakow LS, Guarín M, Wegner CB, Rice TB, Mischler EH. Suspected respiratory tract infection in the tracheostomized child: the pediatric pulmonologist's approach. Chest. 1998;113(6):1549-1554. Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ. Lung deposition and efficiency of nebulized amikacin during escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med. 2002;166(10):1375-1381. Herrmann G, Yang L, Wu H, et al. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis. 2010;202(10):1585-1592. Tamma PD, Turnbull AE, Milstone AM, Lehmann CU, Sydnor ER, Cosgrove SE. Ventilator-associated tracheitis in children: does antibiotic duration matter? Clin Infect Dis. 2011;52(11):1324-1331. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588-2598. Silva RC, Ojano-Dirain CP, Antonelli PJ. Effectiveness of pediatric tracheostomy tube cleaning. Arch Otolaryngol Head Neck Surg. 2012;138(3):251-256. Morrison JM, Hassan A, Kysh L, Dudas RA, Russell CJ. Diagnosis, management, and outcomes of pediatric tracheostomy-associated infections: A scoping review. Pediatr Pulmonol. 2022 May;57(5):1145-1156. Jutras C, Autmizguine J, Chomton M, et al. Inhaled antibiotics for the prevention of respiratory tract infections in children with a tracheostomy. Front Pediatr. 2021;9:633039.